Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.39 |
| ▸ | TET3 | O43151 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839524 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL6839428 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL3776280 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL6838462 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL13062508 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL14643178 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL13015306 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL640339 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL3776284 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL8573155 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112752840-B | Microorganism and method for producing glycolic acid from pentoses and hexoses | 图卢兹国家应用科学研究院 | 2024-11-12 | — | — | CN | claimed |
| CN-117603931-A | Sugar alcohol oxidase and application thereof | 华南理工大学 | 2024-02-27 | — | — | CN | claimed |
| US-11851696-B2 | Microorganisms and process for producing glycolic acid from pentoses and hexoses | Institut National des Sciences Appliquées de Toulouse (FR) | 2023-12-26 | — | — | US | claimed |
| CN-116445384-A | Method for producing BT by fermenting simple detoxified corncob cellulose hydrolysate | 江南大学 | 2023-07-18 | — | — | CN | claimed |
| CN-116326614-B | Flour improver or flour product improver and application thereof | 丰益(上海)生物技术研发中心有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-112752840-B | Microorganism and method for producing glycolic acid from pentoses and hexoses | 图卢兹国家应用科学研究院 | 2024-11-12 | — | — | CN | disclosed |
| CN-117603054-A | Sterilizing reagent and application thereof | 深圳市三启药物开发有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117603931-A | Sugar alcohol oxidase and application thereof | 华南理工大学 | 2024-02-27 | — | — | CN | disclosed |
| US-11851696-B2 | Microorganisms and process for producing glycolic acid from pentoses and hexoses | Institut National des Sciences Appliquées de Toulouse (FR) | 2023-12-26 | — | — | US | disclosed |
| US-20230322837-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2023-10-12 | — | — | US | disclosed |
| EP-4253394-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. (CN) | 2023-10-04 | — | — | EP | disclosed |
| CN-116445384-A | Method for producing BT by fermenting simple detoxified corncob cellulose hydrolysate | 江南大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| US-4314055-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1982-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322837-A1 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | PROC, TMPRSS2, ACE2 | OR51E2 2938/4885PDE4A 4855/4885USP2 2873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.